{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:19:29Z","timestamp":1793747969526,"version":"4.6.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the severe adverse drug reactions following drugs like carbamazepine, allopurinol, and infections. Here we present A 32-year-old woman developed SJS\/TEN after 7\u00a0days of carbamazepine therapy, highlighting the importance of recognizing this risk, particularly in HLA-B*1502 allele carriers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 32-year-old female developed fever, vomiting, and mucocutaneous blisters 7\u00a0days after starting carbamazepine. Lesions spread from the face to the chest, abdomen, and extremities, with throat discomfort and eye discharge. History included prior dizziness episodes.\n<\/jats:p>\n            <jats:p>Examination revealed denuded skin, positive Nikolsky\u2019s sign, and HLA-B*1502 allele positivity. Treatment comprised ceasing carbamazepine, fluid administration, and steroids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>SJS\/TEN manifest with distinct symptoms and often emerge within weeks of drug exposure. Carbamazepine, a frequent trigger, poses higher risks for HLA-B1502 allele carriers. Timely identification and intervention are essential to reduce mortality rates (10-40%). Treatment involves corticosteroids and supportive measures, with pre-carbamazepine HLA-B1502 screening advised, despite potential accessibility constraints.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case underscores the necessity of recognizing carbamazepine-induced SJS\/TEN risk, particularly in HLA-B*1502 carriers. Despite screening challenges, early intervention involving multidisciplinary specialists is essential for favorable outcomes. Increased awareness and proactive measures are vital in preventing and managing these severe reactions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002736","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T16:28:22Z","timestamp":1733934502000},"page":"309-312","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["HLA B*15:02 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: first case report from Nepal with genetic analysis"],"prefix":"10.1097","volume":"87","author":[{"given":"Mandeep D.","family":"Joshi","sequence":"first","affiliation":[{"name":"Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimarsh","family":"Acharya","sequence":"additional","affiliation":[{"name":"KIST Medical College and Teaching Hospital, Gwarko, Lalitpur, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Sapkota","sequence":"additional","affiliation":[{"name":"Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuna","family":"Khati","sequence":"additional","affiliation":[{"name":"Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dissanayake M. L.","family":"Randuwini Dissanayake","sequence":"additional","affiliation":[{"name":"Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Shah","sequence":"additional","affiliation":[{"name":"KIST Medical College and Teaching Hospital, Gwarko, Lalitpur, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanti","family":"Jawarchan","sequence":"additional","affiliation":[{"name":"Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20250926","doi-asserted-by":"crossref","first-page":"7524726","DOI":"10.1155\/2020\/7524726","article-title":"Toxic epidermal necrolysis (TEN)\/Stevens-Johnson syndrome (SJS) epidemiology and mortality rate at King Fahad Specialist Hospital (KFSH) in Qassim Region of Saudi Arabia: a Retrospective Study","volume":"2020","author":"Alajaji","year":"2020","journal-title":"Dermatol Res Pract"},{"key":"R2-20250926","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3390\/biomedicines10092105","article-title":"A review of the systemic treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"10","author":"Chang","year":"2022","journal-title":"Biomedicines"},{"key":"R3-20250926","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg"},{"key":"R4-20250926","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40257-015-0158-0","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an update","volume":"16","author":"Dodiuk-Gad","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"R5-20250926","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R6-20250926","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0378-6323.16782","article-title":"Carbamazepine\u2013the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7 years","volume":"71","author":"Devi","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R7-20250926","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"R8-20250926","doi-asserted-by":"crossref","first-page":"651247","DOI":"10.3389\/fmed.2021.651247","article-title":"Pathogenesis of Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications","volume":"8","author":"Ueta","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R10-20250926","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2017.05.015","article-title":"Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: a meta-analysis","volume":"135","author":"Wang","year":"2017","journal-title":"Epilepsy Res"},{"key":"R11-20250926","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/medicina57090895","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R12-20250926","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5415\/apallergy.0000000000000101","article-title":"Drug-induced Stevens Johnson syndrome and toxic epidermal necrolysis: interpreting the systematic reviews on immunomodulatory therapies","volume":"13","author":"Thong","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"R13-20250926","doi-asserted-by":"crossref","first-page":"2040622319894469","DOI":"10.1177\/2040622319894469","article-title":"Multidisciplinary care in Stevens-Johnson syndrome","volume":"11","author":"Shanbhag","year":"2020","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:00:10Z","timestamp":1758873610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002736","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-07-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}